当前位置:首页 - 行情中心 - 易明医药(002826) - 财务分析

易明医药

(002826)

  

流通市值:14.77亿  总市值:16.00亿
流通股本:1.76亿   总股本:1.91亿

易明医药(002826)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.24亿元,每股收益0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益75898.57万元,未分配利润30592.21万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产98395.65万元,负债22497.09万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入538,300,734.55376,435,471.58171,430,742.25856,734,307.99
营业总成本524,441,373.68363,512,513.02163,151,787.75822,310,337.1
营业利润30,134,506.3318,209,754.2310,698,166.4755,729,362.84
利润总额29,852,127.6418,063,857.7210,645,349.9856,702,600.62
净利润24,399,796.3314,651,791.548,478,872.6546,115,936.95
其他综合收益1,040,284.751,424,774.51-87,171.94-3,729.63
综合收益总额25,440,081.0816,076,566.058,391,700.7146,112,207.32
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计519,832,976.9552,217,671.83578,091,376.85575,009,326.03
非流动资产合计464,123,550.05470,385,052.09437,091,574.36443,195,319.85
资产总计983,956,526.951,022,602,723.921,015,182,951.211,018,204,645.88
流动负债合计216,273,425.09245,879,877.91247,668,650.6261,914,257.24
非流动负债合计8,697,425.428,905,146.969,126,391.646,294,180.38
负债合计224,970,850.51254,785,024.87256,795,042.24268,208,437.62
归属于母公司股东权益合计753,771,536.18762,544,362.41753,570,243.57745,293,911.4
股东权益合计758,985,676.44767,817,699.05758,387,908.97749,996,208.26
负债和股东权益合计983,956,526.951,022,602,723.921,015,182,951.211,018,204,645.88
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计694,947,408.36505,788,422.61224,475,914.77953,392,852.07
经营活动现金流出小计616,841,687.48427,725,023.12192,647,577.34884,939,629.77
经营活动产生的现金流量净额78,105,720.8878,063,399.4931,828,337.4368,453,222.3
投资活动现金流入小计301,539,513.53150,680,345.21-201,482,652.27
投资活动现金流出小计413,578,638.88343,110,185100,219,757203,198,053.03
投资活动产生的现金流量净额-112,039,125.35-192,429,839.79-100,219,757-1,715,400.76
筹资活动现金流入小计9,977,590-22,410-50,000,000
筹资活动现金流出小计70,131,941.92935,277.75462,499.9922,407,999.98
筹资活动产生的现金流量净额-60,154,351.92-957,687.75-462,499.9927,592,000.02
汇率变动对现金及现金等价物的影响393,892.55628,542.61-82,676.2-17,853.88
现金及现金等价物净增加额-93,693,863.84-114,695,585.44-68,936,595.7694,311,967.68
期末现金及现金等价物余额182,588,913.27161,587,191.67207,346,181.35276,282,777.11
TOP↑